Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), bought 8,844 shares at $103.37 ($906K) on 2021-11-26, disclosed to the SEC on 2021-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.50 | 104 | $10K | 1.1% |
| 2 | $102.36 | 3,870 | $396K | 43.7% |
| 3 | $102.36 | 3,870 | $396K | 43.7% |
| 4 | $103.37 | 1,000 | $103K | 11.4% |
| Total | $102.41 avg | 8,844 | $906K | 100% |
| Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |
| NVCR | SELL | 2019-11-26 | $9.8M | — | Filing → |